Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Abstract Background Inhaled nitric oxide (iNO) has been widely used in patients with COVID-19-related acute respiratory distress syndrome (C-ARDS), though its physiological effects and outcome are debated in this setting. The objective of this cohort study was to describe the modalities of iNO use,...

Full description

Bibliographic Details
Main Authors: Armand Mekontso Dessap, Laurent Papazian, Manuella Schaller, Saad Nseir, Bruno Megarbane, Luc Haudebourg, Jean-François Timsit, Jean-Louis Teboul, Khaldoun Kuteifan, Marc Gainnier, Michel Slama, Patrick Houeto, Laurent Lecourt, Alain Mercat, Antoine Vieillard-Baron
Format: Article
Language:English
Published: SpringerOpen 2023-06-01
Series:Annals of Intensive Care
Subjects:
COVID-19
Acute respiratory distress syndrome
Inhaled nitric oxide
Refractory hypoxaemia
ECMO
Online Access:https://doi.org/10.1186/s13613-023-01150-9

Internet

https://doi.org/10.1186/s13613-023-01150-9

Similar Items